A Study to Evaluate a Single Intramuscular Dose of Motavizumab to Treat Children With Respiratory Syncytial Virus (RSV) Illness

Clinical trial NCT00435227 · TERMINATED

Trial details

NCT number: NCT00435227
Sponsor: MedImmune LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Participants Less Than 12 Months of Age With RSV Illness

Start date: 2007-03-20
Primary completion: 2008-05-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.